SC Filed 2020-04-22 Event — SEC 0001213900-20-009830 →

Kellner Petr → Autolus Therapeutics plc AUTL

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (5.1 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 5.11

9,065,436 shares short · +7.9% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $608K

Point72 Asset Mgmt

Other 13D/G Filings on Autolus Therapeutics plc

Filed	Form	Filer	Stake	Shares
2026-08-28	SCHEDULE 13D/A	PPF Group a.s.	5.60%	14,782,275	view →
2022-10-05	SC	PPF Biotech B.V.	—	—	view →
2021-06-23	SC	PPF Capital Partners Fund B.V.	—	—	view →
2021-01-08	SC	Arix Bioscience plc	—	—	view →
2020-08-13	SC	PPF Capital Partners Fund B.V.	—	—	view →
2020-08-03	SC	PPF Capital Partners Fund B.V.	—	—	view →
2020-07-20	SC	PPF Capital Partners Fund B.V.	—	—	view →
2020-07-06	SC	PPF Capital Partners Fund B.V.	—	—	view →
2020-06-15	SC	PPF Capital Partners Fund B.V.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →